New Hepatitis B Drug Trials in Los Angeles

We are conducting Hepatitis B trials with the following drug companies:

• Gilead Sciences (Tenofovir alafenamide fumarate (TAF))

 

Eligible patients must meet the following criteria:

• 18 years of age or older
• Documented evidence of chronic Hep B (eg. HBsAg for >6mo or by medical history)
• E-antigen positive
• HBV DNA level of 20,000 IU/ML
• ALT <60 U/L at screening (males) or > 38U/L (female)

 

Background:

Currently Ruane Medical is conducting clinical trials* on new anti-viral compounds targeting Hepatitis B.

 

Entry into these studies can depend on the specific viral serology of Hepatitis B and the health of the liver, so if a clinical trial is not currently available for your disease state, one could become available in a few months.  

 

If you would like more information concerning a clinical trial for therapy of Hepatitis B, contact our research institute at 323 - 954 - 0400 or fill out the message form here.

 

 

*Clinical trials are research studies that test how new medicines work in people. Each study answers scientific questions and hopes to find better ways to screen for, diagnose, and treat a disease. People who take part in clinical trials have an opportunity to receive new and up-to-date therapy and care from experts. Each clinical trial has a specific plan and rules for who can participate.